Skip to main content
Top
Published in: Pituitary 1/2019

01-02-2019

Physicians’ awareness of gadolinium retention and MRI timing practices in the longitudinal management of pituitary tumors: a “Pituitary Society” survey

Authors: Lisa B. Nachtigall, Niki Karavitaki, Katja Kiseljak-Vassiliades, Luma Ghalib, Hidenori Fukuoka, Luis V. Syro, Daniel Kelly, Maria Fleseriu

Published in: Pituitary | Issue 1/2019

Login to get access

Abstract

Purpose

In view of mounting attention related to possible brain retention of gadolinium-based contrast agents (GBCAs) in patients with normal renal function, our purpose was to detail results from a survey of pituitary experts to assess: 1) the timing interval and frequency of pituitary magnetic resonance imaging (MRI) following surgical and/or medical and/or radiation therapy of pituitary tumors, 2) awareness of the types of GBCAs used and their possible safety issues.

Methods

The Pituitary Society Education Committee composed a survey with 12 multiple choice questions, 8 of which specifically addressed the time interval and frequency of MRI in the longitudinal management of pituitary tumors. The survey was distributed at two meetings; the International Pituitary Neurosurgeons Society conference in San Diego, CA, on February 18th, 2018, and the Pituitary Society Membership and Career Development Forum, Chicago, IL on March 18th, 2018.

Results

There is consensus among pituitary endocrinologists and neurosurgeons that long-term repeated imaging is recommended in most pituitary tumors, although the precise strategy of timing varied depending on the specialist group and the specific clinical context of the adenoma. The data also suggest that International Pituitary Neurosurgeons Society neurosurgeons, as well as Pituitary Society neuroendocrinologists, are sometimes unaware of which contrast agents are used by their institution, and many are also unaware that evidence of long-term brain retention has been reported with the use of GBCAs in patients with normal function.

Conclusions

International pituitary endocrinologists and pituitary neurosurgeons experts suggest ongoing MRIs for the management of pituitary tumors; strategies vary based on clinical context, but also on individual experience and practice.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ersoy H, Rybicki FJ (2007) Biochemical safety profiles of gadolinium-based extracellular contrast agents and nephrogenic systemic fibrosis. J Magn Reson Imaging 26(5):1190–1197PubMedCrossRef Ersoy H, Rybicki FJ (2007) Biochemical safety profiles of gadolinium-based extracellular contrast agents and nephrogenic systemic fibrosis. J Magn Reson Imaging 26(5):1190–1197PubMedCrossRef
2.
go back to reference McDonald RJ, McDonald JS, Kallmes DF, Jentoft ME, Paolini MA, Murray DL et al (2017) Gadolinium deposition in human brain tissues after contrast-enhanced MR imaging in adult patients without intracranial abnormalities. Radiology 285(2):546–554PubMedCrossRef McDonald RJ, McDonald JS, Kallmes DF, Jentoft ME, Paolini MA, Murray DL et al (2017) Gadolinium deposition in human brain tissues after contrast-enhanced MR imaging in adult patients without intracranial abnormalities. Radiology 285(2):546–554PubMedCrossRef
3.
go back to reference Levine D, McDonald RJ, Kressel HY. Gadolinium retention after contrast-enhanced MRI. JAMA. 2018 Levine D, McDonald RJ, Kressel HY. Gadolinium retention after contrast-enhanced MRI. JAMA. 2018
4.
go back to reference Moreno J, Vaz N, Soler J, Carrasco J, Podlipnick S (2018) High signal intensity in the dentate nucleus on unenhanced T1-weighted MR images in melanoma patients receiving macrocyclic gadolinium-based contrast. J Radiol Diagn Methods 1:101 Moreno J, Vaz N, Soler J, Carrasco J, Podlipnick S (2018) High signal intensity in the dentate nucleus on unenhanced T1-weighted MR images in melanoma patients receiving macrocyclic gadolinium-based contrast. J Radiol Diagn Methods 1:101
5.
go back to reference Stojanov D, Aracki-Trenkic A, Benedeto-Stojanov D (2016) Gadolinium deposition within the dentate nucleus and globus pallidus after repeated administrations of gadolinium-based contrast agents—current status. Neuroradiology 58(5):433–441PubMedCrossRef Stojanov D, Aracki-Trenkic A, Benedeto-Stojanov D (2016) Gadolinium deposition within the dentate nucleus and globus pallidus after repeated administrations of gadolinium-based contrast agents—current status. Neuroradiology 58(5):433–441PubMedCrossRef
6.
go back to reference McDonald RJ, Levine D, Weinreb J, Kanal E, Davenport MS, Ellis JH et al. Gadolinium retention: a research roadmap from the 2018 NIH/ACR/RSNA workshop on gadolinium chelates. Radiology. 2018:181151 McDonald RJ, Levine D, Weinreb J, Kanal E, Davenport MS, Ellis JH et al. Gadolinium retention: a research roadmap from the 2018 NIH/ACR/RSNA workshop on gadolinium chelates. Radiology. 2018:181151
7.
go back to reference Dekkers IA, Roos R, van der Molen AJ (2018) Gadolinium retention after administration of contrast agents based on linear chelators and the recommendations of the European Medicines Agency. Eur Radiol 28(4):1579–1584PubMedCrossRef Dekkers IA, Roos R, van der Molen AJ (2018) Gadolinium retention after administration of contrast agents based on linear chelators and the recommendations of the European Medicines Agency. Eur Radiol 28(4):1579–1584PubMedCrossRef
8.
go back to reference Rasschaert M, Emerit A, Fretellier N, Factor C, Robert P, Idee JM et al (2018) Gadolinium retention, brain T1 hyperintensity, and endogenous metals: a comparative study of macrocyclic versus linear gadolinium chelates in renally sensitized rats. Investig Radiol 53(6):328–337CrossRef Rasschaert M, Emerit A, Fretellier N, Factor C, Robert P, Idee JM et al (2018) Gadolinium retention, brain T1 hyperintensity, and endogenous metals: a comparative study of macrocyclic versus linear gadolinium chelates in renally sensitized rats. Investig Radiol 53(6):328–337CrossRef
9.
go back to reference Malayeri AA, Brooks K, Bryant LH, Evers R, Kumar P, Reich DS et al (2016) NIH perspective on reports of gadolinium deposition in the brain. J Am Coll Radiol 13(3):237–241PubMedCrossRef Malayeri AA, Brooks K, Bryant LH, Evers R, Kumar P, Reich DS et al (2016) NIH perspective on reports of gadolinium deposition in the brain. J Am Coll Radiol 13(3):237–241PubMedCrossRef
10.
go back to reference Fitzgerald RT, Agarwal V, Hoang JK, Gaillard F, Dixon A, Kanal E. The impact of gadolinium deposition on radiology practice: an international survey of radiologists. Curr Probl Diagn Radiol. 2018 Fitzgerald RT, Agarwal V, Hoang JK, Gaillard F, Dixon A, Kanal E. The impact of gadolinium deposition on radiology practice: an international survey of radiologists. Curr Probl Diagn Radiol. 2018
11.
go back to reference Ziu M, Dunn IF, Hess C, Fleseriu M, Bodach ME, Tumialan LM et al (2016) Congress of neurological surgeons systematic review and evidence-based guideline on posttreatment follow-up evaluation of patients with nonfunctioning pituitary adenomas. Neurosurgery 79(4):E541–E543PubMedCrossRef Ziu M, Dunn IF, Hess C, Fleseriu M, Bodach ME, Tumialan LM et al (2016) Congress of neurological surgeons systematic review and evidence-based guideline on posttreatment follow-up evaluation of patients with nonfunctioning pituitary adenomas. Neurosurgery 79(4):E541–E543PubMedCrossRef
12.
go back to reference Katznelson L, Laws ER Jr, Melmed S, Molitch ME, Murad MH, Utz A et al (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(11):3933–3951PubMedCrossRef Katznelson L, Laws ER Jr, Melmed S, Molitch ME, Murad MH, Utz A et al (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(11):3933–3951PubMedCrossRef
13.
go back to reference Nieman LK, Biller BM, Findling JW, Murad MH, Newell-Price J, Savage MO et al (2015) Treatment of Cushing’s syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 100(8):2807–2831PubMedCrossRef Nieman LK, Biller BM, Findling JW, Murad MH, Newell-Price J, Savage MO et al (2015) Treatment of Cushing’s syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 100(8):2807–2831PubMedCrossRef
14.
go back to reference Jung JW, Kang HR, Kim MH, Lee W, Min KU, Han MH et al (2012) Immediate hypersensitivity reaction to gadolinium-based MR contrast media. Radiology 264(2):414–422PubMedCrossRef Jung JW, Kang HR, Kim MH, Lee W, Min KU, Han MH et al (2012) Immediate hypersensitivity reaction to gadolinium-based MR contrast media. Radiology 264(2):414–422PubMedCrossRef
15.
go back to reference Golding LP, Provenzale JM (2008) Nephrogenic systemic fibrosis: possible association with a predisposing infection. AJR Am J Roentgenol 190(4):1069–1075PubMedCrossRef Golding LP, Provenzale JM (2008) Nephrogenic systemic fibrosis: possible association with a predisposing infection. AJR Am J Roentgenol 190(4):1069–1075PubMedCrossRef
16.
go back to reference Prince MR, Zhang H, Morris M, MacGregor JL, Grossman ME, Silberzweig J et al (2008) Incidence of nephrogenic systemic fibrosis at two large medical centers. Radiology 248(3):807–816PubMedCrossRef Prince MR, Zhang H, Morris M, MacGregor JL, Grossman ME, Silberzweig J et al (2008) Incidence of nephrogenic systemic fibrosis at two large medical centers. Radiology 248(3):807–816PubMedCrossRef
17.
go back to reference Kanda T, Ishii K, Kawaguchi H, Kitajima K, Takenaka D (2014) High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material. Radiology 270(3):834–841PubMedCrossRef Kanda T, Ishii K, Kawaguchi H, Kitajima K, Takenaka D (2014) High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material. Radiology 270(3):834–841PubMedCrossRef
18.
go back to reference Radbruch A, Weberling LD, Kieslich PJ, Eidel O, Burth S, Kickingereder P et al (2015) Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent. Radiology 275(3):783–791PubMedCrossRef Radbruch A, Weberling LD, Kieslich PJ, Eidel O, Burth S, Kickingereder P et al (2015) Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent. Radiology 275(3):783–791PubMedCrossRef
19.
go back to reference Olchowy C, Cebulski K, Lasecki M, Chaber R, Olchowy A, Kalwak K et al (2017) The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity—a systematic review. PloS ONE 12(2):e0171704PubMedCrossRef Olchowy C, Cebulski K, Lasecki M, Chaber R, Olchowy A, Kalwak K et al (2017) The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity—a systematic review. PloS ONE 12(2):e0171704PubMedCrossRef
20.
go back to reference Kanda T, Fukusato T, Matsuda M, Toyoda K, Oba H, Kotoku J et al (2015) Gadolinium-based contrast agent accumulates in the brain even in subjects without severe renal dysfunction: evaluation of autopsy brain specimens with inductively coupled plasma mass spectroscopy. Radiology 276(1):228–232PubMedCrossRef Kanda T, Fukusato T, Matsuda M, Toyoda K, Oba H, Kotoku J et al (2015) Gadolinium-based contrast agent accumulates in the brain even in subjects without severe renal dysfunction: evaluation of autopsy brain specimens with inductively coupled plasma mass spectroscopy. Radiology 276(1):228–232PubMedCrossRef
21.
go back to reference Errante Y, Cirimele V, Mallio CA, Di Lazzaro V, Zobel BB, Quattrocchi CC (2014) Progressive increase of T1 signal intensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patients with normal renal function, suggesting dechelation. Investig Radiol 49(10):685–690CrossRef Errante Y, Cirimele V, Mallio CA, Di Lazzaro V, Zobel BB, Quattrocchi CC (2014) Progressive increase of T1 signal intensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patients with normal renal function, suggesting dechelation. Investig Radiol 49(10):685–690CrossRef
22.
go back to reference Semelka RC, Ramalho J, Vakharia A, AlObaidy M, Burke LM, Jay M et al (2016) Gadolinium deposition disease: Initial description of a disease that has been around for a while. Magn Reson Imaging 34(10):1383–1390PubMedCrossRef Semelka RC, Ramalho J, Vakharia A, AlObaidy M, Burke LM, Jay M et al (2016) Gadolinium deposition disease: Initial description of a disease that has been around for a while. Magn Reson Imaging 34(10):1383–1390PubMedCrossRef
23.
go back to reference Bussi S, Coppo A, Botteron C, Fraimbault V, Fanizzi A, De Laurentiis E et al (2018) Differences in gadolinium retention after repeated injections of macrocyclic MR contrast agents to rats. J Magn Reson Imaging 47(3):746–752PubMedCrossRef Bussi S, Coppo A, Botteron C, Fraimbault V, Fanizzi A, De Laurentiis E et al (2018) Differences in gadolinium retention after repeated injections of macrocyclic MR contrast agents to rats. J Magn Reson Imaging 47(3):746–752PubMedCrossRef
24.
go back to reference Zarros A, Byrne AM, Boomkamp SD, Tsakiris S, Baillie GS (2013) Lanthanum-induced neurotoxicity: solving the riddle of its involvement in cognitive impairment? Arch Toxicol 87(11):2031–2035PubMedCrossRef Zarros A, Byrne AM, Boomkamp SD, Tsakiris S, Baillie GS (2013) Lanthanum-induced neurotoxicity: solving the riddle of its involvement in cognitive impairment? Arch Toxicol 87(11):2031–2035PubMedCrossRef
25.
go back to reference Woodmansee WW, Carmichael J, Kelly D, Katznelson L (2015) American association of clinical endocrinologists and american college of endocrinology disease state clinical review: postoperative management following pituitary surgery. Endocr Pract 21(7):832–838PubMedCrossRef Woodmansee WW, Carmichael J, Kelly D, Katznelson L (2015) American association of clinical endocrinologists and american college of endocrinology disease state clinical review: postoperative management following pituitary surgery. Endocr Pract 21(7):832–838PubMedCrossRef
Metadata
Title
Physicians’ awareness of gadolinium retention and MRI timing practices in the longitudinal management of pituitary tumors: a “Pituitary Society” survey
Authors
Lisa B. Nachtigall
Niki Karavitaki
Katja Kiseljak-Vassiliades
Luma Ghalib
Hidenori Fukuoka
Luis V. Syro
Daniel Kelly
Maria Fleseriu
Publication date
01-02-2019
Publisher
Springer US
Published in
Pituitary / Issue 1/2019
Print ISSN: 1386-341X
Electronic ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-018-0924-0

Other articles of this Issue 1/2019

Pituitary 1/2019 Go to the issue